| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2000 | WO2000032589A1 Eletriptan hydrobromide monohydrate |
| 06/08/2000 | WO2000032588A2 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 06/08/2000 | WO2000032584A2 Nonsteroidal antiinflammatories |
| 06/08/2000 | WO2000032583A1 Antitumor dibenzofluorene derivatives |
| 06/08/2000 | WO2000032582A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 06/08/2000 | WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors |
| 06/08/2000 | WO2000032578A1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 06/08/2000 | WO2000032577A2 Substituted benzo[de]isoquinoline-1,3-diones |
| 06/08/2000 | WO2000032575A1 β-ALANINE DERIVATIVES AS α4 INTEGRIN INHIBITORS |
| 06/08/2000 | WO2000032570A1 Hydrazine derivatives |
| 06/08/2000 | WO2000032567A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
| 06/08/2000 | WO2000032558A1 Therapeutic product and its use |
| 06/08/2000 | WO2000032557A1 Novel 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia |
| 06/08/2000 | WO2000032556A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 06/08/2000 | WO2000032555A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 06/08/2000 | WO2000032551A1 Sertraline hydrochloride polymorphs |
| 06/08/2000 | WO2000032267A2 Device for locally delivering a drug in a body cavity |
| 06/08/2000 | WO2000032255A1 Polymeric coatings with controlled delivery of active agents |
| 06/08/2000 | WO2000032239A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 06/08/2000 | WO2000032236A1 Peptides carrying substances across the blood brain barrier |
| 06/08/2000 | WO2000032234A1 Topical compositions comprising ascomycins |
| 06/08/2000 | WO2000032232A1 Agent containing an additional local anaesthetic for the treatment of symptoms of parkinson's disease |
| 06/08/2000 | WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | WO2000032214A1 Preventives for hepatopathy |
| 06/08/2000 | WO2000032213A1 ηδT CELL IMMUNOACTIVITY POTENTIATORS CONTAINING SHIITAKE MUSHROOM HYPHA EXTRACT |
| 06/08/2000 | WO2000032210A1 Pharmaceutical composition containing fish oil, vitamin e and c and acetylsalicyl acid against arteriosclerosis |
| 06/08/2000 | WO2000032205A1 Immunomodulatory methods using carbohydrate antigens |
| 06/08/2000 | WO2000032203A1 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof |
| 06/08/2000 | WO2000032202A1 Method for obtaining and using a combination of a purine and a nitrogen monoxide donor for preventing or treating sexual dysfunction |
| 06/08/2000 | WO2000032201A2 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis |
| 06/08/2000 | WO2000032200A1 Cannabimimetic lipid amides as useful medications |
| 06/08/2000 | WO2000032199A1 Use of galanthamine and galanthamine derivatives in the case of acute functional brain damage |
| 06/08/2000 | WO2000032198A1 Use of selected modulators of p2 purinoceptors for the prevention of damage and mortality caused by global cerebral ischemia and ischemia-reperfusion |
| 06/08/2000 | WO2000032197A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 06/08/2000 | WO2000032196A2 Inhibitors of multidrug transporters |
| 06/08/2000 | WO2000032195A1 Preparations for intraurethral administration |
| 06/08/2000 | WO2000032194A2 Use of niacin for the prevention of photocarcinogenesis and photoimmunosuppression |
| 06/08/2000 | WO2000032193A1 Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis |
| 06/08/2000 | WO2000032192A1 Drugs |
| 06/08/2000 | WO2000032191A1 New pharmaceutical composition and the process for its preparation |
| 06/08/2000 | WO2000032190A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases |
| 06/08/2000 | WO2000032189A1 Celecoxib compositions |
| 06/08/2000 | WO2000032188A2 Use of amtolmetin guacyl as an antiinflammatory drug |
| 06/08/2000 | WO2000032187A1 A new pharmaceutical composition |
| 06/08/2000 | WO2000032186A2 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 06/08/2000 | WO2000032185A1 Use of effectors of the central cholinergic nervous system |
| 06/08/2000 | WO2000032184A1 Skin preparations for external use |
| 06/08/2000 | WO2000032183A1 Topiramate and related derivatives for treating schizophrenia |
| 06/08/2000 | WO2000032182A1 The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence |
| 06/08/2000 | WO2000032181A1 Method for reducing free-radical induced injury |
| 06/08/2000 | WO2000032180A2 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituted indolealkanoic acids |
| 06/08/2000 | WO2000032179A2 Use of nicotonic acid derivatives for the treatment of dna damage in skin cells |
| 06/08/2000 | WO2000032178A2 Use of siburamine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 06/08/2000 | WO2000032177A2 Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections |
| 06/08/2000 | WO2000032176A2 Use of 17-ketosteroids for the treatment of toxoplasmosis and cryptosporidosis |
| 06/08/2000 | WO2000032175A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 06/08/2000 | WO2000032174A2 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide |
| 06/08/2000 | WO2000032172A1 An oral formulation for gastrointestinal drug delivery |
| 06/08/2000 | WO2000032171A2 Autoahesive oral transmucosal delivery dosage form |
| 06/08/2000 | WO2000032170A1 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses |
| 06/08/2000 | WO2000032165A1 Milling process for the production of finely milled medicinal substances |
| 06/08/2000 | WO2000032152A2 Compositions and methods for regulating bacterial pathogenesis |
| 06/08/2000 | WO2000032048A1 Novel methods of protecting plants from pathogens |
| 06/08/2000 | WO2000018386A3 Antibiotic compositions for treatment of the eye, ear and nose |
| 06/08/2000 | WO2000018384A3 Antiviral combinations comprising (s)-2-ethyl-7-fluoro-3-oxo-3,4-dihydro-2h-quinoxaline-1-carboxylic acid isopropyl ester and amprenavir |
| 06/08/2000 | WO2000016760A3 New use of prostaglandin e2 antagonists |
| 06/08/2000 | WO2000012535A3 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 06/08/2000 | WO2000012534A3 A method of inhibiting formation of infectious herpes virus particles |
| 06/08/2000 | WO2000012505A3 Triazolopyridazine derivatives for treating anxiety and enhancing cognition |
| 06/08/2000 | WO2000012481A3 Indazole derivatives with 5-ht2 receptor activity________________ |
| 06/08/2000 | WO2000011191A3 Tpl-2/cot kinase and methods of use |
| 06/08/2000 | WO2000010550A3 Reduction of surfactant inactivation in pulmonary surfactant therapy |
| 06/08/2000 | WO2000010533A3 Compositions and methods for treating intracellular infections |
| 06/08/2000 | WO2000009103A9 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 06/08/2000 | WO2000009086A3 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/08/2000 | WO2000007629A3 Peg-urate oxidase conjugates and use thereof |
| 06/08/2000 | WO1999063934A3 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems |
| 06/08/2000 | WO1999058095A3 Pharmaceutical and/or cosmetic compositions containing sea water |
| 06/08/2000 | WO1999033475A8 Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
| 06/08/2000 | DE19959689A1 Liposome composition for tumor, especially breast cancer, therapy comprises an alkyl phospholipid with antineoplastic activity and one or more antiestrogens |
| 06/08/2000 | DE19855963A1 Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung Amphiphilic glyceryl, processes for their preparation and their use |
| 06/08/2000 | DE19855649A1 Dimere alpha-Alkyl-Styrolderivate als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations |
| 06/08/2000 | DE19855566A1 Use of a medicament comprising e.g. heparinoids for treating toothache and dental inflammation and suppuration by application to the skin |
| 06/08/2000 | DE19855426A1 Mittel zur Therapie und Prophylaxe von rheumatisch-arthritischen Erkrankungen und zur Prophylaxe von cardiovaskulären Erkrankungen Means for the therapy and prophylaxis of rheumatic arthritic diseases and for the prophylaxis of cardiovascular diseases |
| 06/08/2000 | DE19855312A1 Verfahren zur fermentativen Herstellung von D-Pantothensäure unter Verwendung coryneformer Bakterien A process for the fermentative preparation of D-pantothenic acid using coryneform bacteria |
| 06/08/2000 | DE19854446A1 Use of hyperforin for treating cancer, or in topical compositions optionally together with hypericin for treating e.g. inflammatory skin disease, skin aging or bacterial skin infections |
| 06/08/2000 | CA2634658A1 Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations |
| 06/08/2000 | CA2503475A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | CA2385845A1 Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids |
| 06/08/2000 | CA2356539A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of african and american trypanosomiasis |
| 06/08/2000 | CA2354158A1 Novel 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia |
| 06/08/2000 | CA2353702A1 Polysaccharide chiral esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or chiral chromatography |
| 06/08/2000 | CA2353645A1 Novel methods of protecting plants from pathogens |
| 06/08/2000 | CA2353613A1 Preparations for intraurethral administration |
| 06/08/2000 | CA2353602A1 Device for locally delivering a drug in a body cavity |
| 06/08/2000 | CA2353576A1 Novel nucleic acid transferring agents, compositions containing them and uses |
| 06/08/2000 | CA2353557A1 Inhibitors of multidrug transporters |
| 06/08/2000 | CA2353502A1 Immunomodulatory methods using carbohydrate antigens |
| 06/08/2000 | CA2353402A1 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
| 06/08/2000 | CA2353394A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |